Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. Asparaginase was approved for medical use in the United States in 1978. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
This report contains market size and forecasts of Medical Asparaginase in India, highlights the following information:
Sales of Medical Asparaginase in India: Value 2019 VS 2023 VS 2030, ($ millions)
Sales of Medical Asparaginase in India: Volume 2019 VS 2023 VS 2030, (K Units)
Sales of Medical Asparaginase in India: Revenue Market Share by Company, 2019-2024
Sales of Medical Asparaginase in India: Volume Market Share by Company, 2019-2024
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Medical Asparaginase will continue to grow rapidly in the future.
The global Medical Asparaginase market size was valued at 404 million in 2023 and is forecast to a readjusted size of US$ 445.8 million by 2030, with a CAGR of 1.4% during the forecast period 2024-2030.While the India Medical Asparaginase market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. India will account for % percent of Medical Asparaginase's global value in 2030, from % in 2023.
Our research team has surveyed the Medical Asparaginase manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, Value, demand, price change, product matrix, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
India Medical Asparaginase Market, By Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
India Medical Asparaginase Market Segment Percentages, By Type, 2023 (%)
India Medical Asparaginase Market, By Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
India Medical Asparaginase Market Segment Percentages, By Application, 2023 (%)
Acute Lymphoblastic Leukemia
The report also provides analysis of leading market participants including:
Key companies Medical Asparaginase revenues in India market, 2019-2024 (Estimated), ($ millions)
Key companies Medical Asparaginase sales in India market, 2019-2024 (Estimated), (K Units)
Further, the report presents profiles of competitors in the market, key players include: